Document is current
Any future updates will be listed below
-
Authors
Tokuhira, Michihide https://orcid.org/0000-0003-3780-5331
Kimura, Yuta
Tabayashi, Takayuki
Watanabe, Naoki
Tsuchiya, Shun
Takaku, Tomoiku
Iriyama, Noriyoshi
Sato, Eriko
Nakazato, Tomonori
Mitsumori, Toru
Ishikawa, Maho
Fujita, Hiroyuki
Kizaki, Masahiro
Ando, Miki
Hatta, Yoshihiro
Iwanaga, Eisaku
Kawaguchi, Tatsuya
- License Information
-
More Information
Article History
Received: 3 February 2023
Revised: 17 April 2023
Accepted: 17 April 2023
First Online: 2 May 2023
Declarations
:
: M. Tokuhira has served on speakers bureaus for Bristol-Myers Squibb, Novartis Pharma K.K., Otsuka Pharmaceutical and Pfizer Inc. T. Takaku and Y. Hatta have served on speakers bureaus for Bristol-Myers Squibb and Novartis Pharma K.K. N. Iriyama has served on speakers bureaus for Bristol-Myers Squibb, Novartis Pharma K.K., Otsuka Pharmaceutical, and Pfizer Inc. M. Kizaki has served on speakers bureaus for Bristol-Myers Squibb and Novartis Pharma K.K. E. Iwanaga has served on speakers bureaus for Bristol-Myers Squibb, Novartis Pharma K.K., Otsuka Pharmaceutical, and Pfizer Inc. T. Kawaguchi has served on speakers bureaus for Novartis Pharma K.K. and Pfizer Inc. The remaining authors declare no competing financial interests.
: All procedures performed in this study were in accordance with the ethical standards of each institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.
